Front Cover

pp.：  1 – 4

Progress in Molecular Biology and Translational Science: Glycosaminoglycans in Development, Health and Disease

pp.：  4 – 5

Copyright page

pp.：  5 – 6

Contents

pp.：  6 – 14

Contributors

pp.：  14 – 17

Preface

pp.：  17 – 19

Glycosaminoglycan (GAG) Biosynthesis and GAG-Binding Proteins

pp.：  19 – 37

Mice Deficient in Glucuronyltransferase-I

pp.：  37 – 53

Mice Deficient in Heparan Sulfate N-Deacetylase/N-Sulfotransferase 1

pp.：  53 – 77

Glucuronyl C5-Epimerase

pp.：  77 – 97

Mice Deficient in Heparan Sulfate 6-O-Sulfotransferase-1

pp.：  97 – 131

The Roles of Chondroitin-4-Sulfotransferase-1 in Development and Disease

pp.：  131 – 151

Roles of Heparan Sulfate in Mammalian Brain Development...

pp.：  151 – 171

Anticoagulant Heparan Sulfate

pp.：  171 – 197

Endothelial Heparan Sulfate in Angiogenesis

pp.：  197 – 231

Hepatic Heparan Sulfate Proteoglycans and Endocytic Clearance of Triglyceride-Rich Lipoproteins

pp.：  231 – 253

Serglycin Proteoglycan Deletion in Mouse Platelets

pp.：  253 – 307

Congenital Disorders of Glycosylation with Emphasis on loss of Dermatan-4-Sulfotransferase

pp.：  307 – 327

Heparan Sulfate Proteoglycans in Amyloidosis

pp.：  327 – 353

Heparin as an Inhibitor of Cancer Progression

pp.：  353 – 369

Vascular Dermatan Sulfate and Heparin Cofactor II

pp.：  369 – 391

Diverse Functions of Glycosaminoglycans in Infectious Diseases

pp.：  391 – 413

Molecular Mechanism Underlines Heparin-Induced Thrombocytopenia and Thrombosis

pp.：  413 – 441

Chondroitin Sulfate and Abnormal Contact System in Rheumatoid Arthritis

pp.：  441 – 461

Activated Contact System and Abnormal Glycosaminoglycans in Lupus and other Auto- and Non-Autoimmune Diseases...

pp.：  461 – 491

Glycosaminoglycans and Activated Contact System in Cancer Patient Plasmas

pp.：  491 – 515

Index

pp.：  515 – 529

Colour plate

pp.：  529 – 545